Search Results
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
sufficient TH concentrations at the cellular level. Therefore, the necessity of TH replacement therapy remains uncertain now, although concentration, energy level and signs of myxoedema of one patient improved after starting T4 replacement therapy, which
Department of Pediatric Endocrinology, Faculty of Medicine, Istinye University, Istanbul, Turkey
Search for other papers by Cengiz Kara in
Google Scholar
PubMed
Search for other papers by Jamala Mammadova in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Ümmet Abur in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Cagri Gumuskaptan in
Google Scholar
PubMed
Search for other papers by Elif İzci Güllü in
Google Scholar
PubMed
Search for other papers by Ayhan Dağdemir in
Google Scholar
PubMed
Search for other papers by Murat Aydın in
Google Scholar
PubMed
high TSH concentration is an appropriate response of the hypothalamic–pituitary axis with reduced sensitivity to thyroid hormone ( 44 ). Likewise, elevated TSH levels in individuals with TSH resistance reflect an appropriately adjusted set point for the
Search for other papers by Irene Campi in
Google Scholar
PubMed
Search for other papers by Marco Dell’Acqua in
Google Scholar
PubMed
Search for other papers by Elisa Stellaria Grassi in
Google Scholar
PubMed
Search for other papers by Maria Cristina Vigone in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
antibody is chemically labeled with a tag molecule, which generates a signal directly proportional to the levels of TSH in the sample. The concentration of TSH is then estimated by comparing this signal with that of a standard curve. The most common
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed
Search for other papers by Kristian Hillert Winther in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Nils Jakob Knudsen in
Google Scholar
PubMed
QualityMetric Inc, Johnston, Lincoln, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Search for other papers by Lutz Schomburg in
Google Scholar
PubMed
Search for other papers by Kamil Demircan in
Google Scholar
PubMed
Search for other papers by Thilo Samson Chillon in
Google Scholar
PubMed
Search for other papers by Jeppe Gram in
Google Scholar
PubMed
Search for other papers by Stinus Gadegaard Hansen in
Google Scholar
PubMed
Internal Medicine Research Unit, University Hospital of Southern Jutland, Aabenraa, Denmark
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
, 25 , 26 , 27 ). To optimise the concentration of selenoprotein P, considered one of the most valid biomarkers of the selenium status, serum selenium should be in the range 120–130 μg/L. To reach this level, the required selenium intake is at least
Search for other papers by Ladan Mehran in
Google Scholar
PubMed
Search for other papers by Atieh Amouzegar in
Google Scholar
PubMed
Search for other papers by Hengameh Abdi in
Google Scholar
PubMed
Search for other papers by Negar Delbari in
Google Scholar
PubMed
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Search for other papers by Elham Madreseh in
Google Scholar
PubMed
Search for other papers by Maryam Tohidi in
Google Scholar
PubMed
Search for other papers by Mohammad Ali Mansournia in
Google Scholar
PubMed
Search for other papers by Fereidoun Azizi in
Google Scholar
PubMed
-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt . J Endocrinol Invest . 2008 May ; 31 ( 5 ): 422 – 31 . http
Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed
Search for other papers by Konstantinos Dimitropoulos in
Google Scholar
PubMed
Search for other papers by Irene Mamali in
Google Scholar
PubMed
Search for other papers by Ioulia Tseti in
Google Scholar
PubMed
Search for other papers by George Sakellaropoulos in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed
thereafter. They were also instructed not to take their LT4 preparation before blood sampling on the scheduled visits for thyroid hormone measurements. We set the therapeutic target range of TSH levels at 0.45–4.12 mIU/L [ 8 ], since Greece is an iodine
Search for other papers by Jacqueline Jonklaas in
Google Scholar
PubMed
Search for other papers by Antonio C. Bianco in
Google Scholar
PubMed
Search for other papers by Anne R. Cappola in
Google Scholar
PubMed
Search for other papers by Francesco S. Celi in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Heike Heuer in
Google Scholar
PubMed
Search for other papers by Elizabeth A. McAninch in
Google Scholar
PubMed
Search for other papers by Lars C. Moeller in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Anna M. Sawka in
Google Scholar
PubMed
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Search for other papers by Colin M. Dayan in
Google Scholar
PubMed
more particularly fT3. Immunoassays commonly used for measuring both fT3 and T3 are more inaccurate than less commonly used tandem mass spectrometry assays [ 72 ], and tend to overestimate T3 levels at low concentrations. T3 levels are affected by
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Bronia Arnott in
Google Scholar
PubMed
Search for other papers by Dawn Teare in
Google Scholar
PubMed
Search for other papers by Shaun Hiu in
Google Scholar
PubMed
Search for other papers by Nicki O’Brien in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is a mild form of thyroid failure diagnosed when serum TSH levels are high and circulating thyroid hormones are within the reference range [ 1 , 2 ]. The prevalence of SCH increases with age and
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Search for other papers by Juliette Abeillon in
Google Scholar
PubMed
Search for other papers by Myriam Moret in
Google Scholar
PubMed
Search for other papers by Pauline Perrin in
Google Scholar
PubMed
Search for other papers by Karim Chikh in
Google Scholar
PubMed
Search for other papers by Véronique Raverot in
Google Scholar
PubMed
Established Facts Maternal TSH receptor-blocking antibodies (TBAbs) are a known cause of transient congenital hypothyroidism. Novel Insights Congenital hypothyroidism due to TBAbs can occur in case of a normal concentration